Amendment to regulation 71

57.  In regulation 71(1), for sub-paragraph (b) (withdrawal of medicinal product from the market)(1) substitute—

“(b) under regulation 69 the licensing authority suspends the use, sale, supply or offer for sale or supply within the United Kingdom of a product to which a UK marketing authorisation relates.”.

(1)

Sub-paragraph (b) was substituted by S.I. 2019/775 as amended by S.I. 2020/1488.